The smart healthcare market size was exhibited at USD 187.19 billion in 2024 and is projected to hit around USD 629.82 billion by 2034, growing at a CAGR of 12.9% during the forecast period 2025 to 2034.
The rising adoption of mHealth, government initiatives to digitize healthcare, and the prevalence of chronic disorders are likely to accentuate the demand for smart healthcare systems. Digitalization has transformed the healthcare industry. The adoption of mHealth has increased substantially in the past few years, majorly owing to the rising usage of smartphones and digitization. As per a United Healthcare Consumer Sentiment Survey, in 2019, approximately 37.0% of Americans rely on the internet or mobile apps for consultations related to their health conditions.
The U.S. smart healthcare market size is evaluated at USD 50.54 billion in 2024 and is projected to be worth around USD 170.05 billion by 2034, growing at a CAGR of 11.66% from 2025 to 2034.
North America dominated the smart healthcare market and accounted for a revenue share of over 35.0% in 2024. This is attributed to supportive government policies for the deployment of digital health and the accessibility of infrastructure with high digital literacy. Furthermore, the presence of key market participants, growing awareness about connected healthcare, high penetration of the internet, and smartphones, along with the usage of health-related apps are a few of the key factors responsible for the growth of the market for smart healthcare.
In March 2020, the American Hospital Association (AMA) stated that nearly 76% of hospitals in the U.S. use telehealth to connect with consulting practitioners and patients owing to its affordability and elevated health care value. Moreover, the successful implementation of e-prescription systems and Electronic Health Records (EHR) in various healthcare centers drive regional market growth.
In the Asia Pacific, the market for smart healthcare is expected to exhibit lucrative growth over the forecast period. Countries such as Japan, Australia, and India exhibit significant potential owing to their developed healthcare IT infrastructure and growing investments in smart healthcare. A rise in the number of government digitalization programs in emerging nations such as China and India is expected to drive the adoption of digital healthcare solutions such as health services. With growing COVID-19 cases in the region, companies are increasingly investing in telemedicine services. On April 14, 2020, Huawei commended the provision of wireless networks, conferencing, and smartphones across Thailand, Bangladesh, and Malaysia. This is intended to increase the adoption of telemedicine practices to combat the COVID-19 pandemic in the region.
| Report Coverage | Details |
| Market Size in 2025 | USD 211.34 Billion |
| Market Size by 2034 | USD 629.82 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 12.9% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Product, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | IBM; Cisco; GE Healthcare; Olympus Corporation; Brooks Automation; Given Imaging, Inc.; Stanley Innerspace; Solstice Medical LLC; Siemens Medical Solutions; Allscripts Healthcare Solutions; Samsung Electronics Corporation; AirStrip Technologies Inc.; Apple Inc.; AT&T Inc.; Logi-Tag; Cerner Corporation; Pepperl+Fuchs; Hurst Green Plastics Ltd.; Bollhoff Group; Wurth Group; McKesson Corporation; Brooks Automation; LogTag |
Based on product, the mHealth segment dominated the market for smart healthcare and accounted for a revenue share of over 36.0% in 2024. The dominance is attributed to high internet usage, smartphones, and the adoption of mHealth apps. Moreover, the introduction of wearable devices from Apple, Fitbit, and MI is influencing the market positively. In April 2020, Proxxi, a Canadian firm launched a wearable device, Halo. This device is designed to ensure compliance with social distancing at a workplace during the ongoing global COVID-19 pandemic. This device would constantly notify of separation to ensure proper social distancing.
RFID kanban system is the fastest-growing segment from 2025 to 2034. The key trends aiding in the adoption of RFID are supply chain management, automation, real-time intelligence, and asset tracking. RFID technology help to identify issues in the workflow of hospitals especially to move patients in and out quickly and more efficiently. Moreover, RFID in Real-Time Location Systems (RTLS) also helps to track newborn babies. Thus, owing to the aforementioned reasons the segment is likely to grow during the forecast period.
Telemedicine accounted for the second-fastest-growing segment in the market for smart healthcare. In the wake of the ongoing COVID-19 outbreak, it is anticipated to boost the adoption and usage of telemedicine by healthcare professionals to connect effectively with their patients. Owing to social distancing globally, virtual care delivery is stepping up as an effective solution for secure and superior communication. Furthermore, companies are collaborating with hospitals to monitor COVID-19 patients. For instance, in March 2020, the All India Institute of Medical Sciences (AIIMS) launched a 24/7 Telemedicine Hub, CoNTeC. It is a real-time telemedicine hub aimed to assist physicians to treat patients.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the smart healthcare market
By Product
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. COUNTRY MARKET: CAGR CALCULATION
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Smart Healthcare Market Snapshot
2.6. Smart Healthcare Market Segment Snapshot
2.7. Smart Healthcare Market Competitive Landscape Snapshot
Chapter 3. Smart Healthcare Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Key Opportunity Prioritized
3.3. Smart Healthcare Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on Smart Healthcare Market
Chapter 4. Smart Healthcare Market: Product Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Smart Healthcare Market: Product Type Movement Analysis, USD Million, 2024 & 2034
4.3. RFID Kanban Systems
4.3.1. RFID Kanban Systems Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.4. RFID Smart Cabinets
4.4.1. RFID Smart Cabinets Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.5. Electronic Health Records (EHR)
4.5.1. Electronic Health Records (EHR) Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.5.2. Web-based HER
4.5.2.1. Web-based HER Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.5.3. Client-server Based HER
4.5.3.1. Client-server Based HER Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.6. Telemedicine
4.6.1. Telemedicine Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.6.2. Hardware
4.6.2.1. Hardware Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.6.3. Software
4.6.3.1. Software Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.6.4. Others
4.6.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.7. mHealth
4.7.1. mHealth Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.7.2. Monitoring Services
4.7.2.1. Monitoring Services Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.7.3. Diagnosis Services
4.7.3.1. Diagnosis Services Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.7.4. Healthcare Systems Strengthening
4.7.4.1. Healthcare Systems Strengthening Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.7.5. Others
4.7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.8. Smart Pills
4.8.1. Smart Pills Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.9. Smart Syringes
4.9.1. Smart Syringes Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
Chapter 5. Smart Healthcare Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Smart Healthcare Market: End Use Movement Analysis, USD Million, 2024 & 2034
5.3. Hospitals
5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
5.4. Homecare Settings
5.4.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
Chapter 6. Smart Healthcare Market: Regional Estimates & Trend Analysis
6.1. Smart Healthcare Market: Regional Movement Analysis, 2024 & 2034
6.2. North America
6.2.1. North America Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Prevalence Insights
6.2.2.4. Regulatory Framework
6.2.2.5. U.S. Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Prevalence Insights
6.2.3.4. Regulatory Framework
6.2.3.5. Canada Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3. Europe
6.3.1. Europe Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Prevalence Insights
6.3.2.4. Regulatory Framework
6.3.2.5. UK Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Prevalence Insights
6.3.3.4. Regulatory Framework
6.3.3.5. Germany Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Prevalence Insights
6.3.4.4. Regulatory Framework
6.3.4.5. France Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Prevalence Insights
6.3.5.4. Regulatory Framework
6.3.5.5. Italy Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Prevalence Insights
6.3.6.4. Regulatory Framework
6.3.6.5. Spain Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Prevalence Insights
6.3.7.4. Regulatory Framework
6.3.7.5. Denmark Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Prevalence Insights
6.3.8.4. Regulatory Framework
6.3.8.5. Sweden Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Prevalence Insights
6.3.9.4. Regulatory Framework
6.3.9.5. Norway Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Prevalence Insights
6.4.2.4. Regulatory Framework
6.4.2.5. Japan Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Prevalence Insights
6.4.3.4. Regulatory Framework
6.4.3.5. China Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Prevalence Insights
6.4.4.4. Regulatory Framework
6.4.4.5. India Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4.5. South Korea
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Prevalence Insights
6.4.5.4. Regulatory Framework
6.4.5.5. South Korea Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Prevalence Insights
6.4.6.4. Regulatory Framework
6.4.6.5. Australia Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Prevalence Insights
6.4.7.4. Regulatory Framework
6.4.7.5. Thailand Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.5. Latin America
6.5.1. Latin America Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Prevalence Insights
6.5.2.4. Regulatory Framework
6.5.2.5. Brazil Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Prevalence Insights
6.5.3.4. Regulatory Framework
6.5.3.5. Mexico Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Prevalence Insights
6.5.4.4. Regulatory Framework
6.5.4.5. Argentina Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Prevalence Insights
6.6.2.4. Regulatory Framework
6.6.2.5. South Africa Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Prevalence Insights
6.6.3.4. Regulatory Framework
6.6.3.5. Saudi Arabia Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Prevalence Insights
6.6.4.4. Regulatory Framework
6.6.4.5. UAE Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Prevalence Insights
6.6.5.4. Regulatory Framework
6.6.5.5. Kuwait Smart Healthcare Market Estimates And Forecasts, 2021 – 2034 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Company Market Share Analysis, 2024
7.3. Strategy Mapping
7.4. Company Profiles/Listing
7.4.1. CISCO
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. IBM
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Given Imaging, Inc.
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Olympus Corporation
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Logi-Tag
7.4.5.1. Overview
7.4.5.2. Financial Performance (Net Revenue)
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Brooks Automation
7.4.6.1. Overview
7.4.6.2. Financial Performance (Net Revenue)
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Stanley Innerspace
7.4.7.1. Overview
7.4.7.2. Financial Performance (Net Revenue)
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Solstice Medical LLC
7.4.8.1. Overview
7.4.8.2. Financial Performance (Net Revenue)
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. GE Healthcare
7.4.9.1. Overview
7.4.9.2. Financial Performance (Net Revenue)
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Siemens Medical Solutions
7.4.10.1. Overview
7.4.10.2. Financial Performance (Net Revenue)
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. McKesson Corp.
7.4.11.1. Overview
7.4.11.2. Financial Performance (Net Revenue)
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. Allscripts Healthcare Solutions
7.4.12.1. Overview
7.4.12.2. Financial Performance (Net Revenue)
7.4.12.3. Product Benchmarking
7.4.12.4. Strategic Initiatives
7.4.13. Samsung Electronics Corporation
7.4.13.1. Overview
7.4.13.2. Financial Performance (Net Revenue)
7.4.13.3. Product Benchmarking
7.4.13.4. Strategic Initiatives
7.4.14. AirStrip Technologies Inc.
7.4.14.1. Overview
7.4.14.2. Financial Performance (Net Revenue)
7.4.14.3. Product Benchmarking
7.4.14.4. Strategic Initiatives
7.4.15. Apple Inc.
7.4.15.1. Overview
7.4.15.2. Financial Performance (Net Revenue)
7.4.15.3. Product Benchmarking
7.4.15.4. Strategic Initiatives
7.4.16. AT&T Inc.
7.4.16.1. Overview
7.4.16.2. Financial Performance (Net Revenue)
7.4.16.3. Product Benchmarking
7.4.16.4. Strategic Initiatives
7.4.17. Cerner Corporation
7.4.17.1. Overview
7.4.17.2. Financial Performance (Net Revenue)
7.4.17.3. Product Benchmarking
7.4.17.4. Strategic Initiatives
7.4.18. Pepperl+Fuchs
7.4.18.1. Overview
7.4.18.2. Financial Performance (Net Revenue)
7.4.18.3. Product Benchmarking
7.4.18.4. Strategic Initiatives
7.4.19. Hurst Green Plastics Ltd.
7.4.19.1. Overview
7.4.19.2. Financial Performance (Net Revenue)
7.4.19.3. Product Benchmarking
7.4.19.4. Strategic Initiatives
7.4.20. Bollhoff Group
7.4.20.1. Overview
7.4.20.2. Financial Performance (Net Revenue)
7.4.20.3. Product Benchmarking
7.4.20.4. Strategic Initiatives
7.4.21. Wurth Group
7.4.21.1. Overview
7.4.21.2. Financial Performance (Net Revenue)
7.4.21.3. Product Benchmarking
7.4.21.4. Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers